Maple Leaf Green World Inc. announced that it has entered into a non-binding letter of intent (“LOI”) dated October 12, 2021 to form a Joint Venture (“JV”) with Biolinear Technologies Inc. (“Biolinear”). This JV will utilize Biolinear’s nano technology to design, produce, and sell cannabinoid-based products with enhanced bioavailability and drug delivery capabilities developed by Biolinear. In the coming weeks, the Company will be conducting further due diligence and continuing its negotiations to complete the JV. All efforts are underway to accelerate this tremendous potential opportunity to expeditiously advance the commercialization of products that utilize Biolinear’s technologies. Maple Leaf is finalizing due diligence on the technologies and anticipates entering a definitive joint venture agreement before the end of October.